Laura McLinn shares her journey with her son, Jordan, who was diagnosed with a progressive rare disease called Duchenne muscular dystrophy. She wants to share her family’s story in hopes of helping others facing Duchenne muscular dystrophy.
Author: healthprofessionalradio
Sage/Biogen Announce Positive Results in Ph. 3 CORAL Depression Drug Trial
Dr. Sagar Parikh, John F. Greden Professor of Depression and Clinical Neuroscience, and Professor of Psychiatry at the University of Michigan, discusses topline results from Sage and Biogen’s Phase 3 CORAL Study evaluating zuranolone, a once-daily, two-week, investigational drug in development for the treatment of major depressive disorder (MDD).
ASCO GU 2022 – ERLEADA ® Real-World Study in Metastatic Castration-Sensitive Prostate Cancer or mCSPC
Dr. Benjamin Lowentritt, MD, FACS, Director, Minimally Invasive Surgery and Robotics and Cancer Care Program at Chesapeake Urology and an investigator on the ERLEADA ® (apalutamide) real-world study discusses the findings that showed a more than 90 percent decline in prostate-specific antigen (PSA) at six months in a majority of patients with mCSPC, reinforcing the positive results found in the clinical trial setting. The patient-reported outcomes study demonstrated that rapid and deep PSA decline is associated with improved health-related quality of life in advanced prostate cancer. These data were presented at the American Society of Clinical Oncology’s Genitourinary Cancers Symposium 2022.
Anthos Therapeutics – Anticoagulant in Development
John Glasspool, CEO of Anthos Therapeutics discusses their lead product, abelacimab, an anticoagulant in development for the prevention of thrombosis. Because of its unique mechanism of action with dual activity against Factor XI and Factor XIa, abelacimab provides reliable and safe anticoagulation without the fear of bleeding that has caused many doctors to stay away from traditional anticoagulants.
WORLDSymposium 2022 – Avalglucosidase alfa Trial Data
Dr. Priya Kishnani, MD, Chen Family Professor of Pediatrics, Chief of the Division of Medical Genetics at Duke University Medical Center and Medical Director of the YT and Alice Chen Pediatrics Genetics and Genomics Center discusses recent data on Sanofi‘s Nexviazyme ® (avalglucosidase alfa) that was presented at 18th annual WORLDSymposium™ which showed sustained improvements in respiratory function and mobility in patients with Pompe disease.
Cervical Cancer Preventive Measures
Dr. Yolanda Lawson, MD, Board Certified OB/GYN and Associate Attending at Baylor University Medical Center discusses cervical cancer which typically develops from human papillomavirus (HPV) and is highly preventable and treatable. She talks about why black women are dying at 1.5 times the rate of white women and what women should know and potentially do.
CareDX – Allosure Lung for Transplant Surveillance
Investigator, Dr. Shambhu Aryal, MD, FCCP, Medical Director, Lung Transplant Program and Director, Inova Sarcoidosis Center, Inova Medical Group discusses the results of the ALARM study, led by the National Institutes of Health (NIH) and published in the “Journal of Heart and Lung Transplantation” that validated the ability of CareDx’s AlloSure ® Lung to detect signs of organ rejection and infection in asymptomatic lung transplant recipients in a real-world, home-based surveillance setting. The study also showed that AlloSure Lung identified episodes of acute rejection and infection that would have been missed using a biopsy strategy alone.
New Trial Starts for Patients with Idiopathic Pulmonary Fibrosis
Dr. Martin Kolb, Director of the Division of Respirology at the Department of Medicine at McMaster University and an expert on interstitial lung disease discusses Horizon Therapeutics‘ Phase 2b pivotal trial to evaluate HZN-825, a lysophosphatidic acid receptor 1 (LPAR1) antagonist to treat people with idiopathic pulmonary fibrosis (IPF), the most common interstitial lung disease
Digital Health and Diabetes Management
Dr. Elizabeth Holt, MD, FACE, Head of Global Medical, Clinical, and Safety at LifeScan, a global leader in glucose monitoring and diabetes management, discusses how digital health solutions enhance the patient/physician relationship, and how cloud-connected devices can improve clinical outcomes. She talks about digital health and how it’s redefining chronic disease management, what physicians need to know now, and how to support the reluctant patient who has not embraced digital health solutions.
How Does Health Insurance Work in Australia?
Are you confused about how health insurance works in Australia? From understanding the different types of insurance to working out what your coverage will be, it can be difficult to get your head around how health insurance works. Keep reading to find out more about how health insurance works in Australia, and don’t forget to take advantage of the iSelect health insurance with no waiting period comparison tool to find the best deal for you.
How Public Health Insurance Works
Public insurance in Australia is a system that provides access to medical services for all citizens and permanent residents. It is funded by both the government and individuals. The system is designed to provide access to a range of health services, including hospital, outpatient and allied health care, as well as prescription medications and medical aids. In Australia, public insurance is provided by a range of different organisations, including the Australian government (through Medicare) and private health insurers. Medicare is the national public insurance scheme and is funded by a combination of general taxation and the Medicare levy. It covers a range of services, including hospital care, doctor visits, diagnostic services, ambulance services and prescription medications. Private health insurers also offer a range of cover options, including hospital cover, extras cover and combined cover.
How Private Health Insurance Works
Private health insurance has become an increasingly popular option for Australians looking to get access to better and more comprehensive health care. With the ever-rising cost of health care, private health insurance provides individuals, families, and businesses with the opportunity to take out a policy that covers the cost of medical services and treatments. Private insurance in Australia is regulated by the Private Health Insurance Act 2007 and the Private Health Insurance Regulations 2021. This legislation outlines the various types of private insurance products that are available, the minimum benefits that must be included in these policies, and the rules for premiums and claims. Private insurance plans are offered by a number of different insurers, each with its own benefits and coverage. Generally, these plans cover hospital treatments, doctor’s visits, specialist services, and some prescription medications. The plans can also include additional benefits such as emergency ambulance transport, dental and optical services, and access to private hospitals and day surgery facilities.
How Overseas Visitor Health Cover Works
Australia is one of the most popular destinations for people from all around the world. With its stunning landscapes and diverse culture, the country offers a wealth of attractions and activities for visitors to enjoy. But there’s one thing you must remember when travelling to Australia—You must have adequate health coverage in place. Overseas Visitor Health Cover (OVHC) is an insurance plan designed for temporary visitors to Australia. It provides cover for the cost of medical and hospital care and can be either a single or a family policy. It’s important to remember that OVHC does not provide coverage for repatriation costs or other medical costs such as dental services and optical coverage. OVHC is available from a range of providers, such as private health funds, travel insurance companies and specialist health cover providers. It is important to compare the features and benefits of the different policies before you decide which one is right for you.
Altogether, health insurance is an important aspect of the Australian healthcare system. It provides access to quality healthcare and helps to cover the cost of medical services, ensuring that all Australians have access to the healthcare they need. Health insurance also helps to reduce the financial burden of medical costs, allowing more citizens to receive the care they need without worrying about the cost.